Technology area: Biotechnology & Pharmaceuticals
16 pending office actions • 4 art units • 5 examiners • 0 of 16 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
ThermoLife International LLC is currently managing 13 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 13 pending actions represent the current active workload for the company's patent prosecution efforts. The focus on Biotechnology & Pharmaceuticals indicates a portfolio centered on life sciences and chemical compositions, which are critical for the company's research and development goals.
The prosecution is distributed among 5 distinct examiners and 4 distinct art units. With 13 pending office actions and only 5 distinct examiners, it is clear that several examiners are handling multiple applications for the company. The use of 4 distinct art units suggests that the technology is concentrated within a few specific regulatory and examination groups at the patent office, which may allow for a more consistent prosecution strategy across the 13 total pending office actions.
HAVLIN, ROBERT H is the busiest examiner for the portfolio, with 6 busiest examiner pending actions. This means that HAVLIN, ROBERT H is responsible for a significant portion of the 13 total pending office actions. This high concentration of workload with a single examiner out of the 5 distinct examiners involved highlights the importance of this specific examiner's perspective on the company's patent filings and the need for a focused legal approach.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (25%) |
| §112 only | 1 (6%) |
| Double-patenting + other | 9 (56%) |
| Multi-statute (no §101) | 2 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAVLIN, ROBERT H | 6 | 51.5% | +28.1% |
| KASSA, TIGABU | 4 | 36.7% | +27.9% |
| PIHONAK, SARAH | 3 | 61.3% | +42.6% |
| ARNOLD, ERNST V | 2 | 48.2% | +12.9% |
| BOATENG, AFUA BAMFOAA | 1 | 46.6% | +64.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19048816 | GINGEROL COMPOSITIONS AND RELATED METHODS | ARNOLD, ERNST V | 10d overdue |
| 18791306 | PERCARBONATE COMPOSITIONS AND USES THEREOF | BOATENG, AFUA BAMFOAA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18399465 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 30d overdue |
| 18399664 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 30d overdue |
| 18399677 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 30d overdue |
| 19048816 | GINGEROL COMPOSITIONS AND RELATED METHODS | ARNOLD, ERNST V | 10d overdue |
| 19562667 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | — |
| 19559685 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | — |
| 19559360 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | — |
| 19559196 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | — |
| Art Unit | Apps |
|---|---|
| 1626 | 6 |
| 1619 | 4 |
| 1627 | 3 |
| 1613 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19562667 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 10, 2026 |
| 19559685 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19559360 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19559196 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19559613 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19559247 | AMINO ACID COMPOSITIONS | HAVLIN, ROBERT H | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 19556470 | AMINO ACID COMPOSITIONS | PIHONAK, SARAH | 1627 | §103§112DP | Non-Final OA | — | Pending | Mar 04, 2026 |
| 19556505 | AMINO ACID COMPOSITIONS | PIHONAK, SARAH | 1627 | §103§112DP | Non-Final OA | — | Pending | Mar 04, 2026 |
| 19556454 | AMINO ACID COMPOSITIONS | PIHONAK, SARAH | 1627 | §103§112DP | Non-Final OA | — | Pending | Mar 04, 2026 |
| 19048816 | GINGEROL COMPOSITIONS AND RELATED METHODS | ARNOLD, ERNST V | 1613 | §103§112 | Non-Final OA | 10d overdue | Pending | Feb 07, 2025 |
| 18824840 | ENHANCED NITRATE, ELEMENTAL METAL, AND AMINO ACID COMPOSITIONS AND METHODS OF USE | ARNOLD, ERNST V | 1613 | §112 | Final Rejection | — | Pending | Sep 04, 2024 |
| 18791306 | PERCARBONATE COMPOSITIONS AND USES THEREOF | BOATENG, AFUA BAMFOAA | — | §102§103 | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18399465 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 1619 | §103 | Final Rejection | 30d overdue | Pending | Dec 28, 2023 |
| 18399664 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 1619 | §103 | Final Rejection | 30d overdue | Pending | Dec 28, 2023 |
| 18399677 | ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE | KASSA, TIGABU | 1619 | §103 | Final Rejection | 30d overdue | Pending | Dec 28, 2023 |
| 16779349 | Enhanced Nitrate Compositions and Methods of Use | KASSA, TIGABU | 1619 | §103 | Final Rejection | — | Pending | Jan 31, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial